Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
Company Details
- Employees
- 32
- Address
- 21 Biopolis Road, Nucleos North Tower,
- co****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- enginebio.com
- HQ
- Singapore, Singapore
Engine Biosciences Questions
Engine Biosciences's website is enginebio.com
Engine Biosciences's LinkedIn profile is https://www.linkedin.com/company/engine-biosciences
Engine Biosciences has
32 employees.
View email and phone details for 32
employees at Engine Biosciences.
Engine Biosciences's industry is
Biotechnology Research
Engine Biosciences's top competitors are
Hummingbird Bioscience,
Nalagenetics,
Immunoscape,
Clavystbio,
Moon Technologies,
Mirxes,
Albatroz Therapeutics,
Tessa Therapeutics Ltd,
Nsg Biolabs,
Allozymes.
Engine Biosciences's support email address is contact@enginebio.com
Engine Biosciences's categories are Biotechnology Research
